| Phosphate levels and cardiovascular disease in the general population. | |
| | |
MedLine Citation:
|
PMID: 19423568 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Phosphate levels are consistently linked with cardiac calcification, cardiovascular disease (CVD), and death in populations with chronic kidney disease. In addition, mechanistic insights suggest that phosphate levels that span the conventional normal range could lead to CVD. Examining these associations in the general population may be relevant because several interventions that may be suitable for primary or secondary prevention trials already exist. This review summarizes findings described from several community-based, prospective, observational studies. Graded associations with cardiac calcification, left ventricular hypertrophy, cardiovascular events, and death were evident, and cardiovascular risk seemed to accelerate with phosphate >3.5 to 4.0 mg/dl. Although the cause of these associations remains to be determined, several existing interventions may allow in-depth examination of the hypothesis that reducing phosphate levels could prevent CVD in the general population. Even as proof-of-concept trials and mechanistic studies are awaited, phosphate levels may be useful for cardiovascular risk stratification in adults without overt kidney disease. |
| | |
Authors:
|
Robert N Foley |
Related Documents
:
|
9046118 - Cardiovascular complications in end-stage renal disease and hemodialysis patients. 19804218 - Gamma-glutamyltransferase and pathogenesis of cardiovascular diseases. 17368598 - Cardiovascular biomarkers: the state of the art in 2006. 14519828 - Tea consumption and cardiovascular disease: effects on endothelial function. 18598628 - Transmission of bartonella henselae by ixodes ricinus. 19935068 - Rheumatic manifestations of endocrine diseases. |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-05-07 |
Journal Detail:
|
Title: Clinical journal of the American Society of Nephrology : CJASN Volume: 4 ISSN: 1555-905X ISO Abbreviation: - Publication Date: 2009 Jun |
Date Detail:
|
Created Date: 2009-06-04 Completed Date: 2009-08-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101271570 Medline TA: Clin J Am Soc Nephrol Country: United States |
Other Details:
|
Languages: eng Pagination: 1136-9 Citation Subset: IM |
Affiliation:
|
Chronic Disease Research Group, Minneapolis, Minnesota 55404, USA. rfoley@cdrg.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Calcinosis
/
epidemiology,
metabolism* Cardiovascular Diseases / epidemiology, metabolism* Humans Hyperphosphatemia / epidemiology, metabolism* Phosphates / blood* Renal Insufficiency, Chronic / epidemiology, metabolism* Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Phosphates |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Hemoglobin variability in nondialysis chronic kidney disease: examining the association with mortali...
Next Document: Frequency of hypoglycemia and its significance in chronic kidney disease.